Literature DB >> 3030533

Human-fms gene is retained in acute lymphoblastic leukemia cells with del(5)(q32).

J H Ohyashiki, K Ohyashiki, A A Sandberg, J Minowada, A J Kinniburgh.   

Abstract

Cytogenetic and molecular investigations of NALM 6 cells (a pre-B-lymphoblastic acute leukemia cell line) revealed them to contain both alleles of the c-fms gene, though the cells had chromosomal changes of 5q- and 12p+. The amount of DNA fragments hybridized to the 1.4 kb PstI/PstI v-fms probe in the NALM 6 cells was approximately the same, when compared with cells of an Epstein-Barr virus-transformed lymphoblastoid cell line with a normal karyotype. Chromosome banding analysis revealed that the breakpoint of the 5q- in the NALM 6 cells was at the proximal portion of the 5q32 band. Chromosomal in situ hybridization of NALM 6 cells showed a significant accumulation of grains on the terminal portions of the abnormal 5q- chromosomes (5q32), as well as on the normal chromosomes #5 with a peak at 5q32-q33. These findings indicate that the human c-fms gene is not deleted in the lymphoblastic leukemia cells with a 5q- studied by us and that it does not show rearrangement or amplification. Thus, the results indicate that a difference in the dosage of the c-fms gene in acute lymphoblastic leukemia cells with the 5q- versus that in cells with the 5q- change in nonlymphocytic neoplasia; in the latter a hemizgosity of the c-fms gene has been suggested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030533     DOI: 10.1016/0165-4608(87)90195-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

Review 1.  Casein kinase 1α: biological mechanisms and theranostic potential.

Authors:  Shaojie Jiang; Miaofeng Zhang; Jihong Sun; Xiaoming Yang
Journal:  Cell Commun Signal       Date:  2018-05-24       Impact factor: 5.712

2.  Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.

Authors:  K Ohyashiki; J H Ohyashiki; H Iwabuchi; T Tauchi; A Iwabuchi; K Toyama
Journal:  Jpn J Cancer Res       Date:  1990-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.